Literature DB >> 29088374

Insights into innate immune signalling in controlling cardiac remodelling.

Yaxing Zhang1,2,3, Zan Huang1,2,3,4, Hongliang Li1,2,3.   

Abstract

Canonical innate immune signalling involves complex cascades: multiple germline-encoded pattern recognition receptors rapidly recognize pathogen-associated or damage-associated molecular patterns to induce the production of cytokines, which bind to their corresponding receptors to orchestrate subsequent host defense phases. Inflammation is a healthy response to pathogenic signals, which are typically rapid and specific, and they terminate once the threat has passed. However, excessive activation or suppression of innate immune or inflammatory responses can lead to considerable human suffering, such as cardiac remodelling. Interestingly, recent studies have revealed that innate immune molecules in the parenchymal cells of the heart influence cardiac homeostasis not only by directly regulating innate immune responses but also through reprogrammed signalling pathways, which are independent of conventional innate immune signalling. Elucidating 'innate immune signalling reprogramming' events will help us better understand the functions of innate immune molecules and, moreover, the pathogenesis of cardiac diseases. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Hypertensive ventricular remodelling; Innate immune signalling; Ischaemic heart disease; Reprogramming

Mesh:

Substances:

Year:  2017        PMID: 29088374     DOI: 10.1093/cvr/cvx130

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

1.  How do endosomal Toll-like receptors sense and extend ischaemic myocardial injury?

Authors:  Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2019-10-01       Impact factor: 10.787

Review 2.  Critical roles of macrophages in pressure overload-induced cardiac remodeling.

Authors:  Dan Yang; Han-Qing Liu; Fang-Yuan Liu; Nan Tang; Zhen Guo; Shu-Qing Ma; Peng An; Ming-Yu Wang; Hai-Ming Wu; Zheng Yang; Di Fan; Qi-Zhu Tang
Journal:  J Mol Med (Berl)       Date:  2020-10-31       Impact factor: 4.599

Review 3.  Common risk factors for heart failure and cancer.

Authors:  Wouter C Meijers; Rudolf A de Boer
Journal:  Cardiovasc Res       Date:  2019-04-15       Impact factor: 10.787

4.  Th1-type immune responses to Porphyromonas gingivalis antigens exacerbate angiotensin II-dependent hypertension and vascular dysfunction.

Authors:  Marta Czesnikiewicz-Guzik; Ryszard Nosalski; Tomasz P Mikolajczyk; Francesca Vidler; Tomasz Dohnal; Elzbieta Dembowska; Delyth Graham; David G Harrison; Tomasz J Guzik
Journal:  Br J Pharmacol       Date:  2018-12-26       Impact factor: 8.739

5.  H2 Protects Against Lipopolysaccharide-Induced Cardiac Dysfunction via Blocking TLR4-Mediated Cytokines Expression.

Authors:  Sihua Tan; Zhiyuan Long; Xiangping Hou; Yujie Lin; Jingting Xu; Xinchao You; Tinghuai Wang; Yaxing Zhang
Journal:  Front Pharmacol       Date:  2019-08-05       Impact factor: 5.810

6.  Sectm1a deficiency aggravates inflammation-triggered cardiac dysfunction through disruption of LXRα signalling in macrophages.

Authors:  Yutian Li; Shan Deng; Xiaohong Wang; Wei Huang; Jing Chen; Nathan Robbins; Xingjiang Mu; Kobina Essandoh; Tianqing Peng; Anil G Jegga; Jack Rubinstein; David E Adams; Yigang Wang; Jiangtong Peng; Guo-Chang Fan
Journal:  Cardiovasc Res       Date:  2021-02-22       Impact factor: 10.787

Review 7.  Can the calcium-regulating hormones counteract the detrimental impact of pro-inflammatory damage-associated molecular patterns in the development of heart failure?

Authors:  Satenik H Adamyan; Knarik R Harutyunyan; Hermine T Abrahamyan; Drastamat N Khudaverdyan; Souren Mkrtchian; Anna S Ter-Markosyan
Journal:  J Investig Med       Date:  2021-05-05       Impact factor: 2.895

Review 8.  The Roles of Noncardiomyocytes in Cardiac Remodeling.

Authors:  Dan Yang; Han-Qing Liu; Fang-Yuan Liu; Nan Tang; Zhen Guo; Shu-Qing Ma; Peng An; Ming-Yu Wang; Hai-Ming Wu; Zheng Yang; Di Fan; Qi-Zhu Tang
Journal:  Int J Biol Sci       Date:  2020-07-02       Impact factor: 6.580

Review 9.  The function of LncRNA-H19 in cardiac hypertrophy.

Authors:  Wenhua Su; Qian Huo; Hao Wu; Lulin Wang; Xiaoxue Ding; Liwen Liang; Liang Zhou; Yan Zhao; Juhua Dan; Hong Zhang
Journal:  Cell Biosci       Date:  2021-08-03       Impact factor: 7.133

10.  The Akt pathway mediates the protective effects of myeloid differentiation protein 1 in pathological cardiac remodelling.

Authors:  Jianye Peng; Gaofeng Zeng; Peng Zhong; Guangji Wang; ChangCheng Lei; Guoping Tian; Jingsong Chen; Jianfeng Wu; Caijie Shen
Journal:  ESC Heart Fail       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.